We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HI
1876
DELISTED
Hillenbrand
HI
$1.46M ﹤0.01%
+34,242
New +$1.52M
RICK icon
1877
RCI Hospitality Holdings
RICK
$199M
$1.46M ﹤0.01%
+15,638
New +$1.3M
WOOF icon
1878
Petco
WOOF
$814M
$1.46M ﹤0.01%
153,489
-582,464
-79% -$5.97M
LVWR.WS icon
1879
CALL
LiveWire Group Warrants
LVWR.WS
$13M
$1.46M ﹤0.01%
300,000
-250,659
-46% -$88.9K
ZTS icon
1880
Zoetis
ZTS
$32.8B
$1.45M ﹤0.01%
9,899
-617,751
-98% -$91.4M
HDV
1881
iShares Core High Dividend ETF
HDV
$14.8B
$1.45M ﹤0.01%
+69,500
New +$1.42M
FBT icon
1882
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.87B
$1.45M ﹤0.01%
9,400
+6,300
+203% +$929K
EWCZ
1883
DELISTED
European Wax Center
EWCZ
$1.43M ﹤0.01%
+114,753
New +$1.65M
TU icon
1884
Telus
TU
$16.9B
$1.42M ﹤0.01%
+73,720
New +$1.52M
BBD icon
1885
Banco Bradesco
BBD
$37.8B
$1.42M ﹤0.01%
+494,087
New +$1.6M
CLINR
1886
CALL
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$1.42M ﹤0.01%
140,862
-313,382
-69% -$44.3K
VRTV
1887
DELISTED
VERITIV CORPORATION
VRTV
$1.42M ﹤0.01%
11,689
-23,845
-67% -$2.89M
PERF.WS
1888
CALL
DELISTED
Perfect Corp Warrants
PERF.WS
$1.42M ﹤0.01%
+198,840
New +$39.1K
ILF icon
1889
iShares Latin America 40 ETF
ILF
$3.76B
$1.42M ﹤0.01%
+61,919
New +$1.54M
BCC icon
1890
Boise Cascade
BCC
$2.75B
$1.42M ﹤0.01%
20,637
+15,525
+304% +$1.06M
RMGCW
1891
CALL
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$1.41M ﹤0.01%
140,095
RS icon
1892
Reliance Steel & Aluminium
RS
$21B
$1.41M ﹤0.01%
6,988
-12,320
-64% -$2.45M
NIRWW
1893
CALL
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$1.41M ﹤0.01%
138,008
XOP icon
1894
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.51B
$1.41M ﹤0.01%
10,400
-20,400
-66% -$2.96M
TUSK icon
1895
Mammoth Energy Services
TUSK
$128M
$1.41M ﹤0.01%
162,728
+7,829
+5% +$44.6K
KTB icon
1896
Kontoor Brands
KTB
$4.77B
$1.4M ﹤0.01%
35,114
-214,487
-86% -$8.36M
HNI icon
1897
HNI Corp
HNI
$3.15B
$1.4M ﹤0.01%
+49,318
New +$1.4M
INTEW
1898
CALL
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$1.4M ﹤0.01%
137,552
BRY
1899
DELISTED
Berry Corp
BRY
$1.4M ﹤0.01%
175,018
+132,620
+313% +$1.14M
MDC
1900
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.4M ﹤0.01%
+44,303
New +$1.37M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.